We are live on ! Find out more
IMMP

Immutep

22 hedge funds and large institutions have $11.2M invested in Immutep in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.03% more ownership

Funds ownership: 0.61%0.64% (+0.03%)

4% less funds holding

Funds holding: 2322 (-1)

22% less capital invested

Capital invested by funds: $14.4M → $11.2M (-$3.12M)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

32% less call options, than puts

Call options by funds: $67K | Put options by funds: $99K

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
5
Reduced
7
Closed
4
Calls
$67K
Puts
$99K
Net Calls
-$32K
Net Calls Change
-$72K
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
26
Citigroup
New York
-$4.97K -2,013 -97%

IMMP Hedge Fund Activity: Q2 2022 in Review

22 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Immutep (IMMP) for Q2 2022, worth a combined $11.2M — down 22% from $14.4M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of IMMP and 3 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 5 added.

The largest buyer was Oracle Investment Management, adding an estimated $1.44M. The largest seller was Morgan Stanley, cutting an estimated $684K.

  • 22 institutional investors held Immutep (IMMP) as of Q2 2022, down from 23 in Q1 2022.
  • Funds reported $11.2M of Immutep stock for Q2 2022, down 22% quarter-over-quarter.
  • 3 funds opened new Immutep positions in Q2 2022 and 4 closed out, a net change of -1 holder.
  • The largest Immutep buyer in Q2 2022 was Oracle Investment Management, an estimated $1.44M added.
  • The largest Immutep seller in Q2 2022 was Morgan Stanley, an estimated $684K sold.

Based on aggregated 13F filings for Q2 2022.